It goes by many names. Methylhexaneamine. 1,3-Dimethylamylamine. 1,3-Dimethylpentylamine. 4-methylhexan 2-amine. Forthane. Floradrene. Geranimine. Sunrise. Hummer. Geranium extract, plant, oil, parts, stem and leaf. For the better part of a year, Nutrition Business Journal has followed the developments in the steadily intensifying story around this compound. It’s a story that’s become especially important in light of the U.S. Food & Drug Administration’s hardnosed stance on synthetic botanicals in its New Dietary Ingredient (NDI) draft guidance. It’s a complicated story that deserves the broad, encompassing overview to follow. Let’s be...
Sign in to view
the full article
This article is part of our paid subscription packages. You need to subscribe (and sign in) to gain access to this Subscriber Only Content.
Why Subscribe to Nutrition Business Journal?
- In-depth perspective on the $226 billion global nutrition industry
- Receive monthly issues and access up to 5 years of back issues
- Downloadable data files, presentations, and more
